Actively Recruiting
Study About Contrast Media
Led by University of Tartu · Updated on 2025-03-30
120
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
Sponsors
U
University of Tartu
Lead Sponsor
N
North Estonia Medical Centre
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.
CONDITIONS
Official Title
Study About Contrast Media
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older
- Diagnosed with adhesive small bowel obstruction by clinical, laboratory, and radiologic evaluation
- No signs of peritonitis and no need for emergency surgery
- Signed informed consent form
You will not qualify if you...
- Patients younger than 18 years
- Small bowel obstruction caused by incarcerated hernias
- Small bowel obstruction caused by carcinomatosis
- Paralytic small bowel obstruction
- Surgery within the past 6 weeks
- Declined participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tartu University Hospital
Tartu, Tartu, Estonia, 50406
Actively Recruiting
Research Team
L
Liis Jaanimäe, MD
CONTACT
C
Ceith Nikkolo, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here